February 11, 2011
Reduce arthritis pain with
vitamin E —
but not just any vitamin E
If you have painful joints from osteoarthritis, vitamin E might be able to help. But a new study says it has to be a special form of the vitamin.
The study followed 64 patients with osteoarthritis of the knee. The researchers randomized the participants to receive one of two nutrients. They took either 1.5 g of glucosamine sulfate (a standard daily dose) or 400 mg of palm vitamin E. They gave the nutrients for six months. At the end of the study, they found that palm vitamin E was as effective as the glucosamine sulfate in reducing symptoms. Of course, it was free of serious side effects.
Palm vitamin E contains about 30% tocopherols and 70% tocotrienols. Tocotrienols have an advantage. Their molecular structure enables them to penetrate deeper into cells. I've told you in the past how the delta form of tocotrienols dramatically helps vascular disease. This form also aids those with cancer. Now we see tocotrienols helping osteoarthritis.
You can find palm tocotrienols online
as Tocomin from Carotech. The delta fraction of tocotrienols is the most active form. So, you might
consider Delta Tocotrienols from Advanced Bionutritionals instead. It should work as well, if not better. Take one daily.
How to beat almost any health problem... by rejuvenating every single cell in your body!
This European breakthrough can reverse the effects of aging in your body's cells. Studies show it leads to healthier cholesterol, a sharper memory, a stronger liver and more.
Click Here To Learn More
PS. Are you losing your vision? Have you had surgery or injections without help? Are you looking for safe alternative methods to improve your eyesight? This Sunday (February 13, 2011), I'll join Dr. Edward Kondrot's radio program to discuss methods to help your vision loss! You can even call in and ask questions (866-536-1100). Regardless of where you live, you can listen to the program simply by visiting the website http://www.1100kfnx.com/ at 7:00 p.m. EST. I hope you'll join us.
Ref: Saudi Med J, 2009; 30(11): 1432-8.